BioPharma Credit (BPCR)

$ 0.88
   
  • Change Today:
    $0.00
  • 52 Week High: $0.9
  • 52 Week Low: $0.8
  • Currency: US Dollars
  • Shares Issued: 1,221.66m
  • Volume: 215,457
  • Market Cap: $1,075.06m
  • RiskGrade: 32

Fundamentals

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Turnover 75.96 68.83 74.68 46.83 90.19
Operating Profit/(Loss) 70.75 61.11 66.95 38.88 83.35
Profit Before Tax 70.75 61.11 66.95 38.88 83.35
Total Dividend Paid n/a n/a n/a n/a n/a
Earnings per Share - Basic 5.38¢ 4.45¢ 4.87¢ 2.83¢ 6.07¢
Earnings per Share - Diluted 5.38¢ 4.45¢ 4.87¢ 2.83¢ 6.07¢
Earnings per Share - Adjusted 5.38¢ 4.45¢ 4.87¢ 2.83¢ 6.07¢
Dividend per Share 3.50¢ 3.50¢ 3.50¢ 3.50¢ 3.50¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Total Fixed Assets 1,225.48 1,331.89 1,226.06 1,346.08 801.00
Net Current Assets 102.51 52.32 145.03 32.91 616.22
Total Assets 1,332.94 1,388.21 1,374.91 1,410.37 1,421.13
Total Liabilities 5.06 4.41 3.82 31.94 11.70
Net Assets 1,327.88 1,383.80 1,371.09 1,378.00 1,409.43
           
Shareholders Funds 1,327.88 1,383.80 1,371.09 1,378.43 1,409.43
Minority Interests n/a n/a n/a n/a n/a
Capital Employed 1,327.88 1,383.80 1,371.09 1,378.00 1,409.43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page